Nanoparticles – Metal & Metal Oxides Market in Healthcare Size, Share and Growth Forecast by Regions 2020-2025

13th July 2020 – The global Nanoparticles – Metal & Metal Oxides Market in Healthcare was worth USD 25.86 billion in 2016 which is anticipated to reach USD 80.74 billion over the forecast period. The existence of a significant amount of metal and metal oxide nanoparticle based drugs that are authorized by the U.S. FDA and prescribed by physicians for the treatment of acute and chronic ailments is attributive for the estimated market.

Furthermore, presence of molecules in the development phase based on the principle of metal oxide nanoparticles is anticipated to boost growth in the coming years. Applications served by these particles include radiotherapy enhancement, drug & gene therapy, thermal ablation, and sensitive diagnostic assay.

This versatile nature with respect to the applicability in health care makes these particles a substantial source of growth in nanomedicine market. Technological innovations pertaining to reduction of adverse effects linked to the application of these particles is expected to influence growth in the forecasted period.

Access Nanoparticles – Metal & Metal Oxides Market in Healthcare Report with TOC @

Scientists and biologists are currently involved in directing R&D to improve understanding of metal based nanoparticles in order to lessen the toxicity problems associated with their usage. Subsequent developments are anticipated to fast-track the development over the forecast period.

The pharmaceutical field is a continually progressing marketplace with vigorous regulatory standards, growing demand for outcome oriented therapy and rising manufacturing and R&D costs for delivering better products than the existing ones. These concerns are persistently generating pressure on manufacturers and government policy makers to meet patient expectations for providing better drugs at a low price.

Gold particles have the biggest share with respect to revenue owing to their vast use in therapeutic advancement. Key factors include small dimensions, less toxicity, and better compatibility that aid in increasing its adoption rate.

Besides, gold nanocages coupled with the coating of the temperature-sensitive polymer are pertinent in a targeted delivery system that on contact with near-infrared radiations, discharge effectors. These are beneficial in checking for interaction with the drug and avails efficient control, thus driving adoption in the various delivery application of the drugs reaching from DNA to the cellular level, disease monitoring, imaging and diagnosis.

Key companies working for the development of metal and metal oxide nanoparticles include Nanobiotix, AstraZeneca, Pfizer Inc., nanoComposix, Merck KGaA, Nanospectra Biosciences, Immunolight LLC, Women’s Hospital and Brigham.

Pharma-biotech entities are engaged in R&D and are carrying out enormous capital investments. Product advancement in human therapeutics and rising demand for better outcomes by the treatment provided are anticipated to boost progress in the coming years.

Request a Sample Copy of Nanoparticles – Metal & Metal Oxides Market in Healthcare Report @

Nanoparticles – Metal & Metal Oxides Regional Outlook (Revenue, USD Billion, 2014 – 2025)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • Asia Pacific
  • Japan
  • China
  • Latin America
  • Brazil
  • Middle East and Africa (MEA)
  • South Africa

Visit Our Blog:

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA


Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!